Table 1.
HMGB1 inhibitors
| HMGB1 inhibitors | Inflammatory disease | Reference-PMID |
|---|---|---|
| Glycyrrhizin | ||
| Diabetic Kidney | 29241180 | |
| Box A | Retinal ischemia/reperfusion | 28542588 |
| Cilostazol | Rheumatoid Arthritis | 25126750 |
| Zeaxanthin | Diabetic retinopathy | 18385086 |
| Resveratrol | ||
| Hypoxic Brain injury | 31362164 | |
| MnTBAP | Diabetic Oxidative Stress | 19833897 |
| Astilbin | Diabetic CV disease | 24211745 |
| N-acetyl cysteine (NAC) | Diabetic Kidney disease | 25896065 |
| Empagliflozin | Diabetic Kidney disease | 31168342 |
| CaMKIV | Diabetic Neuropathic Pain | 27216039 |
| Peptide P5779 | Sepsis, pulmonary hypertension | Reviewed in Yang et al. 2020 DOI 10.3389 |
| M2G7 | Sepsis, arthritis | Reviewed in Yang et al. 2020 DOI 10.3389 |
| Dexmedetomide | Endotoxemia | 24803295 |
| Haptoglobin | Anti-inflammatory | 30568040 |
| Metformin | LPS-induced inflammation | 31772144 |